RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ovid Therapeutics Stock

Ovid Therapeutics Employees 2024

Ovid Therapeutics Employees

67

Ticker

OVID

ISIN

US6904691010

WKN

A2DQ8S

In 2024, Ovid Therapeutics employed 67 people, a 0% change from the 67 number of employees in the previous year.

Ovid Therapeutics Aktienanalyse

What does Ovid Therapeutics do?

Ovid Therapeutics Inc. is a US biopharmaceutical company focused on developing targeted therapies for rare neurological disorders. The company was founded in 2014 and is based in New York. Ovid Therapeutics aims to develop a new class of therapeutics based on regulating the GABA receptor in the brain. GABA is a neurotransmitter responsible for inhibiting neuronal activity in the brain. By modulating the GABA receptor through pharmacological interventions, Ovid Therapeutics hopes to achieve a neuroprotective effect and treat a variety of rare neurological disorders. The company's therapies aim to alleviate symptoms of these diseases and improve brain function by targeting the behavior of GABA receptors. Ovid Therapeutics specializes in researching and developing drugs for three specific conditions: Angelman syndrome, Fragile X syndrome, and tuberous sclerosis complex. Ovid Therapeutics' business model is based on a combination of innovative sciences developed in the start-up model and a focus on strategic partnerships and collaborations with other pharmaceutical and biotech companies. The company's core business involves the clinical development of therapeutic options. Ovid Therapeutics follows a dual-track strategy, developing its own pipeline while also pursuing partnerships with other pharmaceutical companies to secure additional funding and research capabilities. Ovid Therapeutics has an extensive portfolio of preclinical and clinical drugs targeting rare neurological disorders with different drug classes and mechanisms of action. In recent years, Ovid Therapeutics has gained an excellent reputation in the scientific community and won numerous awards. Recently, the company was also recognized as "One to Watch" at the second annual BioCentury's "Beyond Borders." Gaboxadol is the first drug brought to market by Ovid Therapeutics. Gaboxadol is a modulator of the GABAb receptor that has shown excellent results in studies for treating Angelman syndrome. Based on such results, the company is now focused on further developing therapeutic options and conducting more research in the field of rare neurological disorders. Ovid Therapeutics has directed its efforts towards addressing the needs of a patient population that has limited treatment options due to rare neurological disorders. Based on the extensive research results the company has already achieved, its goal is to lay the groundwork for developing novel therapeutics and significantly improving the quality of life for affected patients. Ovid Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Ovid Therapeutics's Employee Base

Ovid Therapeutics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Ovid Therapeutics's operational capacity and future potential.

Year-to-Year Comparison

Assessing Ovid Therapeutics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Ovid Therapeutics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Ovid Therapeutics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Ovid Therapeutics stock

How many employees does Ovid Therapeutics have this year?

Ovid Therapeutics has 67 undefined employees this year.

How many employees did Ovid Therapeutics have compared to the previous year?

Compared to the previous year, Ovid Therapeutics had 0% more employees.

What impact did the number of employees have on the company Ovid Therapeutics?

The number of employees has a direct impact on the efficiency and productivity of Ovid Therapeutics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Ovid Therapeutics?

The number of employees can also have an impact on investors of Ovid Therapeutics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Ovid Therapeutics affect the company?

An increase in equity of Ovid Therapeutics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Ovid Therapeutics's equity affect the company?

A reduction in equity of Ovid Therapeutics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Ovid Therapeutics?

Some factors that can influence the equity of Ovid Therapeutics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Ovid Therapeutics so important for investors?

The equity of Ovid Therapeutics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Ovid Therapeutics influence the company?

The number of employees at Ovid Therapeutics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Ovid Therapeutics evolved in recent years?

In recent years, the number of employees at Ovid Therapeutics has changed by 0.

How many employees does Ovid Therapeutics currently have?

Ovid Therapeutics currently has 67 undefined employees.

Why is the number of employees important for investors of Ovid Therapeutics?

The number of employees is important for investors of Ovid Therapeutics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Ovid Therapeutics take to change the number of employees?

To change the number of employees, Ovid Therapeutics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Ovid Therapeutics pay?

Over the past 12 months, Ovid Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ovid Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Ovid Therapeutics?

The current dividend yield of Ovid Therapeutics is .

When does Ovid Therapeutics pay dividends?

Ovid Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ovid Therapeutics?

Ovid Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Ovid Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ovid Therapeutics located?

Ovid Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ovid Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ovid Therapeutics from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Ovid Therapeutics pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Ovid Therapeutics in the year 2023?

In the year 2023, Ovid Therapeutics distributed 0 USD as dividends.

In which currency does Ovid Therapeutics pay out the dividend?

The dividends of Ovid Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Ovid Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Ovid Therapeutics

Our stock analysis for Ovid Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ovid Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.